Dr. Stuart H. Isaacson, MD
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- Northwestern University Feinberg Medical School (1988)
- Years since graduation
- 38
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 361
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1988Medical school: Northwestern University Feinberg Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
FL license ME0072849
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Boca Raton Regional Hospital Boca Raton, FL
- Bethesda Hospital East Boynton Beach, FL
- Delray Medical Center Delray Beach, FL
Medical groups
- Cora Health Services Inc (1,136 clinicians)
- Stuart H. Isaacson, M.d, P.a. (5 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 361
- Services billed
- 4,869
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 4,600 | 16 |
| Injection, incobotulinumtoxin a, 1 unit | 2,200 | 14 |
| Established patient office or other outpatient visit, 40-54 minutes | 431 | 172 |
| Telephone medical discussion with physician, 21-30 minutes | 294 | 133 |
| Established patient office or other outpatient visit, 30-39 minutes | 205 | 130 |
| Telephone medical discussion with physician, 11-20 minutes | 47 | 37 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 29 | 12 |
| Punch biopsy, each additional skin growth | 27 | 15 |
| Injection of chemical for paralysis of salivary glands on both sides of mouth | 27 | 18 |
| Punch biopsy, first skin growth | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Boca Raton, FL | 530 |
| Rytary (carbidopa/levodopa) Other prescribers in Boca Raton, FL | 220 |
| Nuplazid (pimavanserin tartrate) | 211 |
| Rasagiline Mesylate | 149 |
| Ongentys (opicapone) | 106 |
| Gocovri (amantadine hcl) Other prescribers in Boca Raton, FL | 103 |
| Rivastigmine Other prescribers in Boca Raton, FL | 96 |
| Donepezil Hcl Other prescribers in Boca Raton, FL | 72 |
| Nourianz (istradefylline) | 69 |
| Crexont (carbidopa/levodopa) Other prescribers in Boca Raton, FL | 63 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 365 payments worth $572,387 in total to this clinician.
| Mdd US Operations, LLC | $212,410 |
|---|---|
| Neurocrine Biosciences, Inc. | $99,627 |
| AbbVie Inc. | $57,917 |
| Teva Pharmaceuticals USA, Inc. | $54,245 |
| Amneal Pharmaceuticals LLC | $47,728 |
| Acadia Pharmaceuticals Inc | $37,546 |
| Merz Pharmaceuticals, LLC | $26,243 |
| H. Lundbeck A S | $22,339 |
| Honoraria | $208,038 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $167,000 |
| Consulting Fee | $151,914 |
| Travel and Lodging | $36,443 |
| Food and Beverage | $8,667 |
| Education | $325 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) AUSTEDO XR · Central Nervous System | $19,478 |
| H. Lundbeck A S Dec 30, 2025 | Honoraria | $17,010 |
| Merz Pharmaceuticals, LLC Mar 8, 2025 | Compensation for services other than consulting (speaking, faculty) INBRIJA · Parkinson's Disease | $16,800 |
| Mdd US Operations, LLC Oct 2, 2025 | Honoraria | $11,385 |
| Neurocrine Biosciences, Inc. Mar 25, 2025 | Consulting Fee INGREZZA · Neuropsychiatry | $10,200 |
| Acadia Pharmaceuticals Inc Jul 2, 2025 | Compensation for services other than consulting (speaking, faculty) NUPLAZID · PARKINSONS DISEASE PSYCHOSIS | $9,375 |
| Neurocrine Biosciences, Inc. Aug 13, 2025 | Consulting Fee INGREZZA · Neuropsychiatry | $9,000 |
| Mdd US Operations, LLC Jul 2, 2025 | Honoraria | $8,625 |
| AbbVie Inc. Oct 31, 2025 | Consulting Fee | $8,000 |
| Neurocrine Biosciences, Inc. Nov 26, 2025 | Consulting Fee INGREZZA · Neuropsychiatry | $7,950 |
All 200 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| H. Lundbeck A S Dec 31, 2025 | Honoraria | $4,800 |
| H. Lundbeck A S Dec 31, 2025 | Travel and Lodging travel to NEW YORK, NY | $394 |
| H. Lundbeck A S Dec 30, 2025 | Honoraria | $17,010 |
| Merz Pharmaceuticals, LLC Dec 19, 2025 | Compensation for services other than consulting (speaking, faculty) INBRIJA · Parkinson's Disease | $1,400 |
| AbbVie Inc. Dec 18, 2025 | Compensation for services other than consulting (speaking, faculty) VYALEV · NEUROSCIENCE | $5,600 |
| Amneal Pharmaceuticals LLC Dec 18, 2025 | Honoraria CREXONT · NEUROLOGY | $3,250 |
| F. Hoffmann-la Roche AG Dec 11, 2025 | Consulting Fee | $2,900 |
| AbbVie Inc. Dec 8, 2025 | Travel and Lodging VYALEV · NEUROSCIENCE · travel to ATLANTA, GA · in-kind | $737 |
| AbbVie Inc. Dec 1, 2025 | Consulting Fee | $800 |
| Neurocrine Biosciences, Inc. Nov 26, 2025 | Consulting Fee INGREZZA · Neuropsychiatry | $7,950 |
| AbbVie Inc. Nov 24, 2025 | Consulting Fee | $6,000 |
| AbbVie Inc. Nov 24, 2025 | Consulting Fee | $2,000 |
| Neurocrine Biosciences, Inc. Nov 18, 2025 | Consulting Fee INGREZZA · Neuropsychiatry | $7,500 |
| AbbVie Inc. Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) VYALEV · NEUROSCIENCE | $4,000 |
| Neurocrine Biosciences, Inc. Nov 9, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to Colorado Springs, CO · in-kind | $468 |
| Neurocrine Biosciences, Inc. Nov 8, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to Colorado Springs, CO · in-kind | $448 |
| AbbVie Inc. Nov 8, 2025 | Travel and Lodging BOTOX · NEUROSCIENCE · travel to NEWPORT BEACH, CA · in-kind | $17.98 |
| AbbVie Inc. Nov 7, 2025 | Travel and Lodging BOTOX · NEUROSCIENCE · travel to NEWPORT BEACH, CA · in-kind | $435 |
| AbbVie Inc. Nov 7, 2025 | Travel and Lodging BOTOX · NEUROSCIENCE · travel to NEWPORT BEACH, CA · in-kind | $195 |
| Mdd US Operations, LLC Nov 5, 2025 | Honoraria | $3,312 |
| Merz Pharmaceuticals, LLC Nov 5, 2025 | Consulting Fee INBRIJA · Parkinson's Disease | $2,800 |
| Mdd US Operations, LLC Nov 5, 2025 | Honoraria Gocovri · AMANTADINE | $2,208 |
| Mdd US Operations, LLC Nov 5, 2025 | Honoraria | $1,380 |
| Neurocrine Biosciences, Inc. Nov 5, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to Denver, CO · in-kind | $877 |
| Mdd US Operations, LLC Nov 5, 2025 | Honoraria | $690 |
| Neurocrine Biosciences, Inc. Nov 5, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to Denver, CO · in-kind | $265 |
| Neurocrine Biosciences, Inc. Nov 5, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to Denver, CO · in-kind | $245 |
| Neurocrine Biosciences, Inc. Nov 5, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to Denver, CO · in-kind | $77.83 |
| AbbVie Inc. Oct 31, 2025 | Consulting Fee | $8,000 |
| Merz Pharmaceuticals, LLC Oct 28, 2025 | Compensation for services other than consulting (speaking, faculty) INBRIJA · Parkinson's Disease | $700 |
| Teva Pharmaceuticals USA, Inc. Oct 17, 2025 | Compensation for services other than consulting (speaking, faculty) AUSTEDO XR · Central Nervous System | $7,659 |
| Teva Pharmaceuticals USA, Inc. Oct 17, 2025 | Travel and Lodging AUSTEDO XR · Central Nervous System · travel to Columbia, SC | $1,057 |
| Teva Pharmaceuticals USA, Inc. Oct 17, 2025 | Travel and Lodging AUSTEDO XR · Central Nervous System · travel to Columbia, SC | $845 |
| Mdd US Operations, LLC Oct 5, 2025 | Honoraria | $5,780 |
| Mdd US Operations, LLC Oct 2, 2025 | Honoraria | $11,385 |
| Teva Pharmaceuticals USA, Inc. Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) AUSTEDO XR · Central Nervous System | $5,857 |
| Mdd US Operations, LLC Sep 25, 2025 | Travel and Lodging travel to Cleveland, OH · in-kind | $5,600 |
| AbbVie Inc. Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) VYALEV · NEUROSCIENCE | $5,600 |
| Mdd US Operations, LLC Sep 25, 2025 | Honoraria | $690 |
| Mdd US Operations, LLC Sep 25, 2025 | Honoraria | $345 |
| Mdd US Operations, LLC Sep 19, 2025 | Honoraria | $5,780 |
| Mdd US Operations, LLC Sep 18, 2025 | Honoraria | $5,780 |
| Neurocrine Biosciences, Inc. Sep 11, 2025 | Consulting Fee INGREZZA · Neuropsychiatry | $5,100 |
| Mdd US Operations, LLC Sep 11, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $398 |
| Neurocrine Biosciences, Inc. Sep 10, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $5,700 |
| Neurocrine Biosciences, Inc. Sep 10, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to GASTONIA, NC · in-kind | $398 |
| Mdd US Operations, LLC Sep 10, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $398 |
| Amneal Pharmaceuticals LLC Sep 9, 2025 | Honoraria CREXONT · NEUROLOGY | $2,275 |
| Mdd US Operations, LLC Sep 4, 2025 | Honoraria | $5,780 |
| Mdd US Operations, LLC Sep 4, 2025 | Honoraria | $2,890 |
| Mdd US Operations, LLC Sep 4, 2025 | Honoraria | $1,445 |
| AbbVie Inc. Sep 2, 2025 | Consulting Fee VYALEV · NEUROSCIENCE | $1,600 |
| AbbVie Inc. Sep 1, 2025 | Consulting Fee VYALEV · NEUROSCIENCE | $800 |
| AbbVie Inc. Aug 29, 2025 | Consulting Fee VYALEV · NEUROSCIENCE | $800 |
| AbbVie Inc. Aug 28, 2025 | Consulting Fee | $4,800 |
| Acadia Pharmaceuticals Inc Aug 28, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,000 |
| AbbVie Inc. Aug 27, 2025 | Consulting Fee | $2,800 |
| AbbVie Inc. Aug 27, 2025 | Consulting Fee VYALEV · NEUROSCIENCE | $2,800 |
| AbbVie Inc. Aug 27, 2025 | Consulting Fee VYALEV · NEUROSCIENCE | $2,400 |
| Merz Pharmaceuticals, LLC Aug 26, 2025 | Consulting Fee INBRIJA · Parkinson's Disease | $2,100 |
| Merz Pharmaceuticals, LLC Aug 26, 2025 | Consulting Fee INBRIJA · Parkinson's Disease | $700 |
| Merz Pharmaceuticals, LLC Aug 26, 2025 | Consulting Fee INBRIJA · Parkinson's Disease | $700 |
| Merz Pharmaceuticals, LLC Aug 26, 2025 | Consulting Fee INBRIJA · Parkinson's Disease | $700 |
| Mdd US Operations, LLC Aug 26, 2025 | Honoraria | $690 |
| Teva Pharmaceuticals USA, Inc. Aug 25, 2025 | Consulting Fee AUSTEDO XR · Central Nervous System | $980 |
| Acadia Pharmaceuticals Inc Aug 20, 2025 | Compensation for services other than consulting (speaking, faculty) NUPLAZID · PARKINSONS DISEASE PSYCHOSIS | $7,500 |
| Neurocrine Biosciences, Inc. Aug 13, 2025 | Consulting Fee INGREZZA · Neuropsychiatry | $9,000 |
| AbbVie Inc. Aug 9, 2025 | Compensation for services other than consulting (speaking, faculty) VYALEV · NEUROSCIENCE | $4,600 |
| Mdd US Operations, LLC Jul 28, 2025 | Honoraria | $5,780 |
| Mdd US Operations, LLC Jul 28, 2025 | Compensation for services other than consulting (speaking, faculty) | $137 |
| Mdd US Operations, LLC Jul 19, 2025 | Honoraria | $863 |
| Neurocrine Biosciences, Inc. Jul 19, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $332 |
| Neurocrine Biosciences, Inc. Jul 19, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $146 |
| Mdd US Operations, LLC Jul 15, 2025 | Compensation for services other than consulting (speaking, faculty) | $7.74 |
| Mdd US Operations, LLC Jul 15, 2025 | Compensation for services other than consulting (speaking, faculty) | $1.25 |
| Neurocrine Biosciences, Inc. Jul 14, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $2,400 |
| Mdd US Operations, LLC Jul 9, 2025 | Honoraria | $1,380 |
| Mdd US Operations, LLC Jul 9, 2025 | Honoraria | $1,380 |
| Acadia Pharmaceuticals Inc Jul 2, 2025 | Compensation for services other than consulting (speaking, faculty) NUPLAZID · PARKINSONS DISEASE PSYCHOSIS | $9,375 |
| Mdd US Operations, LLC Jul 2, 2025 | Honoraria | $8,625 |
| Mdd US Operations, LLC Jul 2, 2025 | Honoraria | $1,380 |
| Mdd US Operations, LLC Jul 2, 2025 | Honoraria | $1,380 |
| Acadia Pharmaceuticals Inc Jun 27, 2025 | Compensation for services other than consulting (speaking, faculty) NUPLAZID · PARKINSONS DISEASE PSYCHOSIS | $1,500 |
| Neurocrine Biosciences, Inc. Jun 25, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $2,400 |
| Neurocrine Biosciences, Inc. Jun 18, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $1,500 |
| Mdd US Operations, LLC Jun 17, 2025 | Honoraria | $3,933 |
| Mdd US Operations, LLC Jun 17, 2025 | Honoraria | $2,622 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 12, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $406 |
| Neurocrine Biosciences, Inc. Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $5,700 |
| Neurocrine Biosciences, Inc. Jun 10, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to KNOXVILLE, TN · in-kind | $599 |
| Neurocrine Biosciences, Inc. Jun 10, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to KNOXVILLE, TN · in-kind | $270 |
| Acadia Pharmaceuticals Inc Jun 6, 2025 | Travel and Lodging NUPLAZID · PARKINSONS DISEASE PSYCHOSIS · travel to DENVER, CO · in-kind | $311 |
| Mdd US Operations, LLC Jun 5, 2025 | Honoraria | $5,780 |
| Mdd US Operations, LLC Jun 5, 2025 | Travel and Lodging travel to Elmhurst, NY · in-kind | $588 |
| Mdd US Operations, LLC Jun 5, 2025 | Travel and Lodging travel to Philadelphia, PA · in-kind | $243 |
| Acadia Pharmaceuticals Inc Jun 4, 2025 | Compensation for services other than consulting (speaking, faculty) NUPLAZID · PARKINSONS DISEASE PSYCHOSIS | $1,900 |
| Amneal Pharmaceuticals LLC Jun 3, 2025 | Honoraria CREXONT · NEUROLOGY | $2,275 |
| Mdd US Operations, LLC May 30, 2025 | Travel and Lodging travel to Dallas, TX · in-kind | $304 |
| Mdd US Operations, LLC May 28, 2025 | Honoraria | $5,780 |
| Amneal Pharmaceuticals LLC May 28, 2025 | Honoraria CREXONT · NEUROLOGY | $5,525 |
| Mdd US Operations, LLC May 28, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $285 |
| Amneal Pharmaceuticals LLC May 23, 2025 | Honoraria CREXONT · NEUROLOGY | $2,275 |
| Amneal Pharmaceuticals LLC May 21, 2025 | Travel and Lodging CREXONT · NEUROLOGY · travel to MEMPHIS, TN · in-kind | $247 |
| Mdd US Operations, LLC May 19, 2025 | Consulting Fee | $6,728 |
| Mdd US Operations, LLC May 19, 2025 | Travel and Lodging travel to New York, NY · in-kind | $850 |
| AbbVie Inc. May 13, 2025 | Consulting Fee VYALEV · NEUROSCIENCE | $1,200 |
| Acadia Pharmaceuticals Inc May 9, 2025 | Compensation for services other than consulting (speaking, faculty) NUPLAZID · PARKINSONS DISEASE PSYCHOSIS | $3,000 |
| AbbVie Inc. May 9, 2025 | Travel and Lodging VYALEV · NEUROSCIENCE · travel to BROOKLYN, NY · in-kind | $182 |
| Mdd US Operations, LLC May 8, 2025 | Honoraria | $5,780 |
| Amneal Pharmaceuticals LLC May 8, 2025 | Consulting Fee CREXONT · NEUROLOGY | $5,200 |
| Acadia Pharmaceuticals Inc May 8, 2025 | Compensation for services other than consulting (speaking, faculty) NUPLAZID · PARKINSONS DISEASE PSYCHOSIS | $1,500 |
| AbbVie Inc. May 8, 2025 | Consulting Fee BOTOX · BOTOX THERAPEUTIC | $800 |
| AbbVie Inc. May 6, 2025 | Travel and Lodging travel to BROOKLYN, NY · in-kind | $361 |
| Mdd US Operations, LLC May 2, 2025 | Honoraria | $4,420 |
| Amneal Pharmaceuticals LLC Apr 30, 2025 | Education CREXONT · NEUROLOGY · in-kind | $325 |
| Mdd US Operations, LLC Apr 25, 2025 | Honoraria | $5,780 |
| Amneal Pharmaceuticals LLC Apr 25, 2025 | Honoraria ONGENTYS · NEUROLOGY | $2,275 |
| Mdd US Operations, LLC Apr 25, 2025 | Travel and Lodging travel to New Orleans, LA · in-kind | $857 |
| Mdd US Operations, LLC Apr 24, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $5,600 |
| Mdd US Operations, LLC Apr 17, 2025 | Honoraria | $5,780 |
| Mdd US Operations, LLC Apr 15, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $2,008 |
| Mdd US Operations, LLC Apr 13, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $749 |
| Mdd US Operations, LLC Apr 9, 2025 | Consulting Fee | $5,520 |
| Neurocrine Biosciences, Inc. Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $4,800 |
| Neurocrine Biosciences, Inc. Apr 8, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $3,900 |
| Mdd US Operations, LLC Apr 8, 2025 | Honoraria | $1,530 |
| Mdd US Operations, LLC Apr 6, 2025 | Honoraria | $5,780 |
| Mdd US Operations, LLC Apr 4, 2025 | Honoraria | $167 |
| Mdd US Operations, LLC Apr 4, 2025 | Honoraria Apokyn · APOMORPHINE HYDROCHLORIDE | $167 |
| Mdd US Operations, LLC Apr 4, 2025 | Honoraria Gocovri · AMANTADINE | $167 |
| Teva Pharmaceuticals USA, Inc. Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) AUSTEDO XR · Central Nervous System | $19,478 |
| Mdd US Operations, LLC Apr 2, 2025 | Honoraria | $1,530 |
| Mdd US Operations, LLC Mar 31, 2025 | Honoraria | $690 |
| Mdd US Operations, LLC Mar 28, 2025 | Honoraria | $690 |
| Mdd US Operations, LLC Mar 28, 2025 | Honoraria | $690 |
| Mdd US Operations, LLC Mar 28, 2025 | Honoraria | $690 |
| Mdd US Operations, LLC Mar 28, 2025 | Honoraria | $690 |
| Mdd US Operations, LLC Mar 28, 2025 | Honoraria | $690 |
| Mdd US Operations, LLC Mar 28, 2025 | Honoraria | $690 |
| Mdd US Operations, LLC Mar 28, 2025 | Honoraria | $518 |
| Mdd US Operations, LLC Mar 28, 2025 | Honoraria | $518 |
| Amneal Pharmaceuticals LLC Mar 26, 2025 | Honoraria CREXONT · NEUROLOGY | $2,275 |
| Neurocrine Biosciences, Inc. Mar 25, 2025 | Consulting Fee INGREZZA · Neuropsychiatry | $10,200 |
| Mdd US Operations, LLC Mar 21, 2025 | Consulting Fee | $5,520 |
| Mdd US Operations, LLC Mar 18, 2025 | Consulting Fee | $5,520 |
| Mdd US Operations, LLC Mar 18, 2025 | Consulting Fee | $690 |
| Genentech USA, Inc. Mar 15, 2025 | Consulting Fee | $6,220 |
| Genentech USA, Inc. Mar 15, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $561 |
| Genentech USA, Inc. Mar 15, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $232 |
| Acadia Pharmaceuticals Inc Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) NUPLAZID · PARKINSONS DISEASE PSYCHOSIS | $2,800 |
| Mdd US Operations, LLC Mar 13, 2025 | Honoraria | $5,780 |
| Mdd US Operations, LLC Mar 13, 2025 | Honoraria | $2,890 |
| Mdd US Operations, LLC Mar 13, 2025 | Travel and Lodging travel to New York City, NY · in-kind | $556 |
| Mdd US Operations, LLC Mar 12, 2025 | Honoraria | $5,780 |
| Mdd US Operations, LLC Mar 11, 2025 | Consulting Fee | $1,380 |
| Mdd US Operations, LLC Mar 11, 2025 | Consulting Fee | $345 |
| Mdd US Operations, LLC Mar 11, 2025 | Consulting Fee | $345 |
| Merz Pharmaceuticals, LLC Mar 8, 2025 | Compensation for services other than consulting (speaking, faculty) INBRIJA · Parkinson's Disease | $16,800 |
| Merz Pharmaceuticals, LLC Mar 7, 2025 | Travel and Lodging INBRIJA · Parkinson's Disease · travel to Irving, TX · in-kind | $184 |
| Amneal Pharmaceuticals LLC Mar 6, 2025 | Consulting Fee CREXONT · NEUROLOGY | $6,825 |
| Amneal Pharmaceuticals LLC Mar 6, 2025 | Consulting Fee CREXONT · NEUROLOGY · in-kind | $189 |
| Amneal Pharmaceuticals LLC Mar 4, 2025 | Honoraria CREXONT · NEUROLOGY | $3,575 |
| Amneal Pharmaceuticals LLC Mar 4, 2025 | Honoraria CREXONT · NEUROLOGY | $2,600 |
| Amneal Pharmaceuticals LLC Mar 4, 2025 | Honoraria CREXONT · NEUROLOGY | $2,600 |
| Neurocrine Biosciences, Inc. Mar 1, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $486 |
| Neurocrine Biosciences, Inc. Mar 1, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $188 |
| Neurocrine Biosciences, Inc. Feb 28, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $390 |
| Neurocrine Biosciences, Inc. Feb 28, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $188 |
| Amneal Pharmaceuticals LLC Feb 25, 2025 | Honoraria CREXONT · NEUROLOGY | $2,275 |
| Mdd US Operations, LLC Feb 25, 2025 | Honoraria | $1,530 |
| Mdd US Operations, LLC Feb 24, 2025 | Consulting Fee | $1,380 |
| Mdd US Operations, LLC Feb 24, 2025 | Consulting Fee | $1,380 |
| Neurocrine Biosciences, Inc. Feb 24, 2025 | Consulting Fee INGREZZA · Neuropsychiatry | $795 |
| Mdd US Operations, LLC Feb 24, 2025 | Consulting Fee | $518 |
| Neurocrine Biosciences, Inc. Feb 21, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $4,800 |
| Neurocrine Biosciences, Inc. Feb 21, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to HONOLULU, HI · in-kind | $3,430 |
| Mdd US Operations, LLC Feb 21, 2025 | Honoraria | $1,380 |
| Mdd US Operations, LLC Feb 21, 2025 | Honoraria | $1,380 |
| Mdd US Operations, LLC Feb 21, 2025 | Honoraria | $345 |
| Neurocrine Biosciences, Inc. Feb 20, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $4,240 |
| Neurocrine Biosciences, Inc. Feb 19, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $5,035 |
| Neurocrine Biosciences, Inc. Feb 19, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to HONOLULU, HI · in-kind | $1,962 |
| Teva Pharmaceuticals USA, Inc. Feb 18, 2025 | Compensation for services other than consulting (speaking, faculty) AUSTEDO XR · Central Nervous System | $4,505 |
| Acadia Pharmaceuticals Inc Feb 15, 2025 | Compensation for services other than consulting (speaking, faculty) NUPLAZID · PARKINSONS DISEASE PSYCHOSIS | $5,250 |
| Acadia Pharmaceuticals Inc Feb 15, 2025 | Compensation for services other than consulting (speaking, faculty) NUPLAZID · PARKINSONS DISEASE PSYCHOSIS | $840 |
| Teva Pharmaceuticals USA, Inc. Feb 14, 2025 | Compensation for services other than consulting (speaking, faculty) AUSTEDO XR · Central Nervous System | $4,505 |
| Tanabe Pharma America, Inc. Feb 14, 2025 | Consulting Fee | $735 |
| Teva Pharmaceuticals USA, Inc. Feb 13, 2025 | Compensation for services other than consulting (speaking, faculty) AUSTEDO XR · Central Nervous System | $4,505 |
| Teva Pharmaceuticals USA, Inc. Feb 12, 2025 | Compensation for services other than consulting (speaking, faculty) AUSTEDO XR · Central Nervous System | $4,505 |
| Amneal Pharmaceuticals LLC Feb 6, 2025 | Honoraria ONGENTYS · NEUROLOGY | $3,250 |
| AbbVie Inc. Feb 6, 2025 | Travel and Lodging travel to IRVINE, CA · in-kind Company’s descriptionM25-076 | $253 |
| Biogen, Inc. Feb 5, 2025 | Consulting Fee | $2,740 |
| Mdd US Operations, LLC Jan 31, 2025 | Consulting Fee | $345 |
| Mdd US Operations, LLC Jan 31, 2025 | Consulting Fee | $345 |
| Mdd US Operations, LLC Jan 29, 2025 | Honoraria Apokyn · APOMORPHINE HYDROCHLORIDE | $5,780 |
| Mdd US Operations, LLC Jan 29, 2025 | Honoraria Apokyn · APOMORPHINE HYDROCHLORIDE | $2,890 |
| Neurocrine Biosciences, Inc. Jan 18, 2025 | Consulting Fee INGREZZA · Neuropsychiatry | $5,830 |
| Neurocrine Biosciences, Inc. Jan 18, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to Clearwater, FL · in-kind | $332 |
| Mdd US Operations, LLC Jan 10, 2025 | Consulting Fee | $7,935 |
| Mdd US Operations, LLC Jan 10, 2025 | Travel and Lodging travel to Washington, DC · in-kind | $486 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 25 industry-funded studies in 2025, from 10 companies. The companies reported $1,032,373 in research payments for these studies, mostly to the institutions running them.
- A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA) (MASCOT)
H. Lundbeck A S - A Study of Lu AF82422 in Participants With Multiple System Atrophy
H. Lundbeck A S · Active, not recruiting · NCT05104476 - A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients With Multiple System Atrophy (TOPAS-MSA)
Teva Pharmaceuticals USA, Inc. - ITI-214-202
Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.) - Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease
AbbVie Inc. · Active, not recruiting · NCT06107426 - A Phase 2b efficacy safety trial of Prasinezumab in patients with early Parkinson s Disease
Genentech, Inc. - A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease
UCB SA · Completed · NCT04658186 - A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
Ipsen Innovation · Recruiting · NCT06937931 - Phase II study in early stage Parkinson s Disease Patients
Roche Tcrc, Inc. - An Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's Disease
UCB SA · Terminated · NCT05543252
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.